NORLEVO

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

LEVONORGESTREL

から入手可能:

CTS LTD

ATCコード:

G03AC03

医薬品形態:

TABLETS

構図:

LEVONORGESTREL 1.5 MG

投与経路:

PER OS

処方タイプ:

Not required

製:

LABORATOIRE HRA PHARMA , FRANCE

治療群:

LEVONORGESTREL

治療領域:

LEVONORGESTREL

適応症:

Emergency contraceptive.

承認日:

2015-05-31

情報リーフレット

1
PATIENT PACKAGE INSERT IN ACCORDANCE WITH
THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed without a doctor’s prescription
NORLEVO 1.5 MG
Tablets
The active ingredient and its quantity:
The tablet contains: Levonorgestrel 1.5 mg.
For the inactive ingredients and allergens - see the paragraph in
Section 2
“Important information about some of the ingredients of the
medicine” and
Section 6 “Further Information”.
The medicine is dispensed without a prescription for women and girls
over 14 years old. For girls less than 14 years old, the medicine is
dispensed with a doctor's prescription only. If you have started
treatment without consultation, refer to your doctor as soon as
possible.
Read the leaflet carefully in its entirety before using the medicine.
This
leaflet contains concise information about the medicine. If you have
further
questions, refer to the doctor or pharmacist. You must take the
medication
according to all the instructions in the dosage section of this
leaflet. Consult a
pharmacist if you need more information.
1. WHAT IS THE MEDICINE INTENDED FOR?
NorLevo is intended for preventing pregnancy up to 72 hours (3 days)
after
having unplanned, unprotected intercourse or after rape, or when there
is
concern that the contraceptives used are insufficient.
Therapeutic group: Progestogens (female hormones).
The medicine is intended as an emergency contraceptive when taken up
to 72
hours (3 days) after having unprotected intercourse, or if your
routine
contraceptive methods have failed.
NorLevo contains a synthetic hormone called levonorgestrel.
NorLevo prevents pregnancy in 99% of the situations when it is taken
within 72
hours from the date of unprotected intercourse.
Patient Safety Information Card:
In addition to the leaflet, NorLevo has a patient safety information
card.
This card contains important safety information that you should be
aware of
and follow before and after taking NorLevo.
Refer to the patient safety information card and the patient leaflet
befo